BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mitizodone phosphate readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Mitizodone phosphate\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04984512-833@assetmemo.bio
DTSTAMP:20261121T005615Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Mitizodone phosphate: Phase 2/3 readout est. (NCT04984512)
DESCRIPTION:Mitizodone phosphate\, phase 2/3\, Major Depressive Disorder.\n
 Study: The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Trea
 tment of Patient With Major Depressive Disorder\nEstimated primary complet
 ion: July 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/mitiz
 odone-phosphate#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT04984512
URL:https://assetmemo.bio/drug/mitizodone-phosphate#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
